Literature DB >> 17535052

Salivary Flow Rates andPharmacokinetics in Healthy Japaneseand Caucasian VolunteersAdministered Oral Pilocarpine : A Comparative Study.

Richard Wasnich1, Susan Gallagher, Stacy Stanek, John R Macdonald, Guhan Balan, Yasuhiro Omori, Imao Mikoshiba.   

Abstract

Entities:  

Year:  2003        PMID： 17535052     DOI： 10.2165/00044011-200323060-00005

Source DB:  PubMed          Journal:  Clin Drug Investig        ISSN： 1173-2563            Impact factor:   3.580


× No keyword cloud information.
  9 in total

Review 1.  Sjögren's syndrome: mechanisms of pathogenesis involve interaction of immune and neurosecretory systems.

Authors:  Robert I Fox; Michael Stern
Journal:  Scand J Rheumatol Suppl       Date:  2002

2.  Serum pilocarpine esterase activity and response to oral pilocarpine.

Authors:  C Aromdee; J P Fawcett; M M Ferguson; R Ledger
Journal:  Biochem Mol Med       Date:  1996-10

3.  A pilot study of the disposition of pilocarpine in plasma, saliva and urine after a single oral dose.

Authors:  C Aromdee; M M Ferguson; R Ledger; J Wall
Journal:  Eur J Pharm Sci       Date:  1999-05       Impact factor: 4.384

4.  Post-radiation severe xerostomia relieved by pilocarpine: a prospective French cooperative study.

Authors:  J C Horiot; F Lipinski; S Schraub; C Maulard-Durdux; R J Bensadoun; J M Ardiet; M Bolla; Y Coscas; F Baillet; B Coche-Dequéant; M Urbajtel; X Montbarbon; S Bourdin; M Wibault; M Alfonsi; G Calais; P Desprez; F Pene; M Lapeyre; J Vinke; J Maral
Journal:  Radiother Oncol       Date:  2000-06       Impact factor: 6.280

Review 5.  Pilocarpine, an old drug; a new formulation.

Authors:  S E Taylor; I al-Hashimi
Journal:  Tex Dent J       Date:  1996-10

6.  Pharmacokinetics of pilocarpine in subjects with varying degrees of renal function.

Authors:  J V St Peter; L J Lambrecht; B W Gunderson; S A Andersen; S C Gallagher; S K Swan
Journal:  J Clin Pharmacol       Date:  2000-12       Impact factor: 3.126

7.  Oral pilocarpine for post-irradiation xerostomia in patients with head and neck cancer.

Authors:  J T Johnson; G A Ferretti; W J Nethery; I H Valdez; P C Fox; D Ng; C C Muscoplat; S C Gallagher
Journal:  N Engl J Med       Date:  1993-08-05       Impact factor: 91.245

8.  Pilocarpine tablets for the treatment of dry mouth and dry eye symptoms in patients with Sjögren syndrome: a randomized, placebo-controlled, fixed-dose, multicenter trial. P92-01 Study Group.

Authors:  F B Vivino; I Al-Hashimi; Z Khan; F G LeVeque; P L Salisbury; T K Tran-Johnson; C C Muscoplat; M Trivedi; B Goldlust; S C Gallagher
Journal:  Arch Intern Med       Date:  1999-01-25

9.  A multicenter, randomized, double-blind, placebo-controlled, dose-titration study of oral pilocarpine for treatment of radiation-induced xerostomia in head and neck cancer patients.

Authors:  F G LeVeque; M Montgomery; D Potter; M B Zimmer; J W Rieke; B W Steiger; S C Gallagher; C C Muscoplat
Journal:  J Clin Oncol       Date:  1993-06       Impact factor: 44.544
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.